Introduction to molecular targeted radiosensitizers: opportunities and challenges
H Willers, I Eke - Molecular Targeted Radiosensitizers: Opportunities …, 2020 - Springer
The practice of radiation oncology is currently primarily based on precise technical delivery
of highly conformal, image-guided radiation treatments. The precision medicine revolution …
of highly conformal, image-guided radiation treatments. The precision medicine revolution …
Preclinical strategies for testing of targeted radiosensitizers
Use of radiation for cancer therapy began shortly after the discovery of X-rays in 1895.
Technological advances over the ensuing 120 years have enabled the development of …
Technological advances over the ensuing 120 years have enabled the development of …
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
SH Lin, TJ George, E Ben-Josef… - Journal of the …, 2013 - academic.oup.com
The first annual workshop for preclinical and clinical development of radiosensitizers took
place at the National Cancer Institute on August 8–9, 2012. Radiotherapy is one of the most …
place at the National Cancer Institute on August 8–9, 2012. Radiotherapy is one of the most …
Translating Targeted Radiosensitizers into the Clinic
DE Citrin, KA Camphausen - Molecular Targeted Radiosensitizers …, 2020 - Springer
Radiation therapy is commonly used in the curative treatment of cancer. Despite recent
progress in the techniques of radiation delivery and treatment, local recurrence after …
progress in the techniques of radiation delivery and treatment, local recurrence after …
On the path to seeking novel radiosensitizers
D Katz, E Ito, FF Liu - International Journal of Radiation Oncology* Biology …, 2009 - Elsevier
Radiation therapy is a highly effective cancer treatment modality, and extensive
investigations have been undertaken over the years to augment its efficacy in the clinic. This …
investigations have been undertaken over the years to augment its efficacy in the clinic. This …
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
KJ Harrington, LJ Billingham, TB Brunner… - British journal of …, 2011 - nature.com
There is a growing appreciation of the potential value of combining novel molecularly-
targeted drugs with radiotherapy or chemoradiotherapy. Such approaches have the …
targeted drugs with radiotherapy or chemoradiotherapy. Such approaches have the …
Molecular targeted radiosensitizers: opportunities and challenges
H Willers, I Eke - 2020 - books.google.com
Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader
with a comprehensive review of key pre-clinical research components required to identify …
with a comprehensive review of key pre-clinical research components required to identify …
Molecular targets for tumor radiosensitization
PJ Tofilon, K Camphausen - Chemical reviews, 2009 - ACS Publications
It is estimated that in 2008 1.4 million patients in North America will be diagnosed with a
nonskin form of cancer (www. cancer. org), of which seventy-five percent will receive …
nonskin form of cancer (www. cancer. org), of which seventy-five percent will receive …
Screening and validation of molecular targeted radiosensitizers
The development of molecular targeted drugs with radiation and chemotherapy is critically
important for improving the outcomes of patients with hard-to-treat, potentially curable …
important for improving the outcomes of patients with hard-to-treat, potentially curable …
Preclinical in vivo evaluation of novel radiosensitizers by local tumor control experiments
K Schneider, N Ebert, I Kurth, M Baumann - … Opportunities and Challenges, 2020 - Springer
Over the past several years, significant technological and biological progress has been
made in radiation oncology with focus on the development of new treatment schemes to …
made in radiation oncology with focus on the development of new treatment schemes to …